help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-0655
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caperuto, L. C.
Right arrow Articles by Bordin, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caperuto, L. C.
Right arrow Articles by Bordin, S.
Endocrinology Vol. 149, No. 12 6326-6335
Copyright © 2008 by The Endocrine Society

Modulation of Bone Morphogenetic Protein-9 Expression and Processing by Insulin, Glucose, and Glucocorticoids: Possible Candidate for Hepatic Insulin-Sensitizing Substance

Luciana Chagas Caperuto1, Gabriel Forato Anhê1, Tavane David Cambiaghi, Eliana Hiromi Akamine, Daniella do Carmo Buonfiglio, José Cipolla-Neto, Rui Curi and Silvana Bordin

Department of Biological Sciences (L.C.C.), Federal University of São Paulo, 04023-900 São Paulo, Brazil; and Department of Physiology and Biophysics (G.F.A., T.D.C., E.H.A., D.C.B., J.C.-B., R.C., S.B.), Institute of Biomedical Sciences, University of São Paulo, 05508-900 São Paulo, Brazil

Address all correspondence and requests for reprints to: Silvana Bordin, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, Av Lineu Prestes, 1524-ICB 1-Sala 125, 05508-900 São Paulo, Brasil. E-mail: sbordin{at}icb.usp.br.

Bone morphogenetic protein 9 (BMP-9), a member of the TGF-β superfamily predominantly expressed in nonparenchymal liver cells, has been demonstrated to improve glucose homeostasis in diabetic mice. Along with this therapeutic effect, BMP-9 was proposed as a candidate for the hepatic insulin-sensitizing substance (HISS). Whether BMP-9 plays a physiological role in glucose homeostasis is still unknown. In the present study, we show that BMP-9 expression and processing is severely reduced in the liver of insulin-resistant rats. BMP-9 expression and processing was directly stimulated by in situ exposition of the liver to the combination of glucose and insulin and oral glucose in overnight fasted rats. Additionally, prolonged fasting (72 h) abrogated refeeding-induced BMP-9 expression and processing. Previous exposition to dexamethasone, a known inductor of insulin resistance, reduced BMP-9 processing stimulated by the combination of insulin and glucose. Finally, we show that neutralization of BMP-9 with an anti-BMP-9 antibody induces glucose intolerance and insulin resistance in 12-h fasted rats. Collectively, the present results demonstrate that BMP-9 plays an important role in the control of glucose homeostasis of the normal rat. Additionally, BMP-9 is expressed and processed in an HISS-like fashion, which is impaired in the presence of insulin resistance. BMP-9 regulation according to the feeding status and the presence of diabetogenic factors reinforces the hypothesis that BMP-9 might exert the role of HISS in glucose homeostasis physiology.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society